These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 16198847

  • 1. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
    Rienstra M, Van Veldhuisen DJ, Hagens VE, Ranchor AV, Veeger NJ, Crijns HJ, Van Gelder IC, RACE Investigators.
    J Am Coll Cardiol; 2005 Oct 04; 46(7):1298-306. PubMed ID: 16198847
    [Abstract] [Full Text] [Related]

  • 2. Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
    Groenveld HF, Crijns HJ, Rienstra M, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC, RACE investigators.
    Am Heart J; 2009 Nov 04; 158(5):785-91. PubMed ID: 19853699
    [Abstract] [Full Text] [Related]

  • 3. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G, Torbicki A, Kosior D, Szulc M, Zawadzka M, Pierścińska M, Kołodziej P, Stopiński M, Wozakowska-Kapłon B, Achremczyk P, Rabczenko D.
    Kardiol Pol; 2003 Jul 04; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [Abstract] [Full Text] [Related]

  • 4. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.
    Heart; 2009 Jun 04; 95(11):924-30. PubMed ID: 19282313
    [Abstract] [Full Text] [Related]

  • 5. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):1001-9. PubMed ID: 16949494
    [Abstract] [Full Text] [Related]

  • 6. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.
    Hagens VE, Vermeulen KM, TenVergert EM, Van Veldhuisen DJ, Bosker HA, Kamp O, Kingma JH, Tijssen JG, Crijns HJ, Van Gelder IC, RACE study group.
    Eur Heart J; 2004 Sep 05; 25(17):1542-9. PubMed ID: 15342174
    [Abstract] [Full Text] [Related]

  • 7. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Jenkins LS, Brodsky M, Schron E, Chung M, Rocco T, Lader E, Constantine M, Sheppard R, Holmes D, Mateski D, Floden L, Prasun M, Greene HL, Shemanski L.
    Am Heart J; 2005 Jan 05; 149(1):112-20. PubMed ID: 15660042
    [Abstract] [Full Text] [Related]

  • 8. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 05; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 9. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group.
    N Engl J Med; 2002 Dec 05; 347(23):1834-40. PubMed ID: 12466507
    [Abstract] [Full Text] [Related]

  • 10. Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
    Rienstra M, Van Gelder IC, Hagens VE, Veeger NJ, Van Veldhuisen DJ, Crijns HJ.
    Eur Heart J; 2006 Feb 05; 27(3):357-64. PubMed ID: 16275661
    [Abstract] [Full Text] [Related]

  • 11. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G, Biancoli S, Sassone B, Pancaldi LG.
    Ital Heart J Suppl; 2002 Jan 05; 3(1):81-90. PubMed ID: 11899578
    [Abstract] [Full Text] [Related]

  • 12. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.
    Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, Kremastinos DT, Breithardt G, Cokkinos DV, Crijns HJ.
    J Am Coll Cardiol; 2007 Feb 06; 49(5):572-7. PubMed ID: 17276181
    [Abstract] [Full Text] [Related]

  • 13. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL, Safford RE, AFFIRM trial, RACE trial.
    Card Electrophysiol Rev; 2003 Dec 06; 7(4):366-9. PubMed ID: 15071255
    [Abstract] [Full Text] [Related]

  • 14. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.
    de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA.
    Arch Intern Med; 2005 Feb 14; 165(3):258-62. PubMed ID: 15710787
    [Abstract] [Full Text] [Related]

  • 15. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B, Straumann E, Bertel O.
    Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188
    [Abstract] [Full Text] [Related]

  • 16. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct 18; 144(4):597-607. PubMed ID: 12360154
    [Abstract] [Full Text] [Related]

  • 17. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G, Diemberger I, Biffi M, Domenichini G, Martignani C, Valzania C, Branzi A.
    Int J Clin Pract; 2007 May 18; 61(5):748-56. PubMed ID: 17493088
    [Abstract] [Full Text] [Related]

  • 18. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
    Curtis AB, Seals AA, Safford RE, Slater W, Tullo NG, Vidaillet H, Wilber DJ, Slee A.
    Am Heart J; 2005 Feb 18; 149(2):304-8. PubMed ID: 15846269
    [Abstract] [Full Text] [Related]

  • 19. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
    Siu CW, Jim MH, Zhang X, Chan YH, Pong V, Kwok J, Kung AW, Lau CP, Tse HF.
    Am J Cardiol; 2009 Feb 15; 103(4):540-3. PubMed ID: 19195517
    [Abstract] [Full Text] [Related]

  • 20. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators.
    Am Heart J; 2005 Apr 15; 149(4):645-9. PubMed ID: 15990747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.